ArticleCancer research and treatment2026

H3K18la Facilitates TRA2A-Mediated Alternative Splicing of STIL, Suppressing Ferroptosis and Cisplatin Treatment Sensitivity in Ovarian Cancer.

Mingyang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.